EUVIMEDEUVIMED entdecken
Crossref

Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion

Subhojit Paul, Kaushik Das, Arnab Ghosh, Akash Chatterjee, Avinandan Bhoumick, Abhimanyu Basu, Prosenjit Sen

Journal of Thrombosis and Haemostasis · 2023

DOI: 10.1016/j.jtha.2023.08.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023. Verfasst von Subhojit Paul und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, Indian Association for the Cultivation of Science, Kolkata, India. Hauptthemen laut MEDLINE: B7-H1 Antigen, Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Indian Association for the Cultivation of Science, Council of Scientific and Industrial Research, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Immunotherapy for breast cancer has not gained significant success. Coagulation factor VIIa (FVIIa)-tissue factor (TF) mediated activation of protease-activated receptor 2 (PAR2) is shown to promote metastasis and secretion of the immune-modulatory cytokines but the role of FVIIa in cancer immunology is still not well understood. OBJECTIVES: Here, we aim to investigate whether FVIIa protects breast cancer cells from CD8 T-cell-mediated killing. METHODS: Peripheral blood mononuclear cell-derived CD8 T cells were cocultured with vehicle or FVIIa pretreated MDAMB468 cells. The proliferation and activity of CD8 T cells were measured by flow cytometry and ELISA. An allograft model, using wild-type or TF/PAR2-deleted 4T1 cells, was employed to determine the effect of FVIIa on breast cancer immune evasion in vivo. RESULTS: Here, we demonstrate that TF-FVIIa induces programmed death-ligand 1 (PD-L1) in breast cancer cells by activating PAR2. PAR2 activation triggers large tumor suppressor kinase 1 (LATS1) inactivation leading to loss of yes-associated protein (YAP)/transcriptional coactivator with PDZ-binding motif (TAZ) phosphorylation and subsequent nuclear localization of YAP/TAZ. YAP/TAZ inhibition reduces PD-L1 expression and increases CD8 T-cell activity. We further demonstrate that, apart from transcriptional induction of PD-L1, PAR2 activation also increases PD-L1 stability by enhancing its glycosylation through N-glycosyltransferases STT3A and STT3B. CONCLUSION: In a mouse model of breast cancer, tumor cell-specific PAR2 depletion leads to PD-L1 downregulation and increases anti-PD-1 immunotherapy efficacy. In conclusion, we showed that FVIIa-mediated signaling cascade in cancer cells serves as a tumor intrinsic mechanism of immunosuppression to promote cancer immune evasion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenNeoplasmsAnimalsMiceCell Line, TumorFactor VIIaImmune EvasionLeukocytes, MononuclearThromboplastinReceptor, PAR-2

Stichwörter der Autor:innen

CD8 T cellsbreast cancercoagulation factor FVIIaimmune evasionprotease-activated receptor 2tissue factor

Substanzen

CD274 protein, humanB7-H1 AntigenFactor VIIaThromboplastinReceptor, PAR-2

Autor:innen und Institutionen

  • School of Biological Sciences, Indian Association for the Cultivation of Science, Kolkata, India.
  • Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, Texas.
  • Department of General Surgery, Institute of Postgraduate Medical Education and Research, Kolkata, West Bengal, India.
  • School of Biological Sciences, Indian Association for the Cultivation of Science, Kolkata, India. Electronic address: bcps@iacs.res.in.

Förderung

  • Indian Association for the Cultivation of Science
  • Council of Scientific and Industrial Research, India

Zitieren

APA

Paul, S., Das, K., Ghosh, A., Chatterjee, A., Bhoumick, A., Basu, A., & Sen, P. (2023). Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.08.008

Vancouver

Paul S, Das K, Ghosh A, Chatterjee A, Bhoumick A, Basu A, et al. Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion. Journal of Thrombosis and Haemostasis. 2023. doi:10.1016/j.jtha.2023.08.008

BibTeX
@article{Paul2023,
  author = {Paul, Subhojit and Das, Kaushik and Ghosh, Arnab and Chatterjee, Akash and Bhoumick, Avinandan and Basu, Abhimanyu and Sen, Prosenjit},
  title = {Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2023},
  doi = {10.1016/j.jtha.2023.08.008}
}
Kostenlos starten →